-
Evaluating the ICER Special Report in the Context of Medicare Drug Price Negotiations: Implications for Manufacturer Pricing and Evidence Strategies
Mar 10, 2025, 14:00 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated with Ovarian Cancer in the Brazilian Private Market
Mar 10, 2025, 14:00 PM -
Administrative Incidence and Prevalence of Multiple Myeloma Using Administrative Claims Data From a Large Health Maintenance Organization in Colombia, 2015–2023
Mar 10, 2025, 14:00 PM -
Impacts of Annual Wage on Insulin Adherence in Diabetes
Mar 10, 2025, 14:00 PM -
Advancing Equitable Access to Cystic Fibrosis Treatment in Brazil: Strategies for Implementing National Clinical Guidelines
Mar 10, 2025, 14:00 PM -
From Bias to Confidence: Exploring Quantitative Bias Analysis’ (QBA’s) Role in Matching Adjusted Indirect Treatment Comparison
Mar 10, 2025, 14:00 PM -
Assessing the Acceptance of Single-Arm Trials in Health Technology Appraisals: A Review of NICE, CADTH, HAS, and NCPE Appraisals in 2024
Mar 10, 2025, 14:00 PM -
Telehealth Use Among Adultswith Sickle Cell Disease in Texas Medicaid Before and During the Covid-19 Pandemic
Mar 10, 2025, 14:00 PM -
Real World Data Comparative Effectiveness Study of a Bilayered Living Cellular Construct and a Dehydrated Human Amnion Chorion Membrane for the Treatment of Pressure Injuries
Mar 10, 2025, 14:00 PM -
Revisiting Archetypes: New Archetypes for Strategic Global Value Evidence Planning
Mar 10, 2025, 14:00 PM -
Disparities in COVID-19 Vaccination Uptake by Social Vulnerability Index: A US nationwide study
Mar 10, 2025, 14:00 PM -
Cost-per-Event Analysis of Risankizumab in Comparison to Ustekinumab for the Treatment of Patients With Moderate-to-Severe Crohn’s Disease in Brazil
Mar 10, 2025, 14:00 PM -
Predicted Effectiveness of First- and Second-Line Treatment Sequences in Advanced or Recurrent Endometrial Cancer
Mar 10, 2025, 14:00 PM -
The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in the UK
Mar 10, 2025, 14:00 PM -
Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study
Mar 10, 2025, 14:00 PM -
A Real-World Perspective of Quadruple Treatment Patterns for 1L Multiple Myeloma Patients across North and South America, Europe and Asia
Mar 10, 2025, 14:00 PM -
Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Guatemala
Mar 10, 2025, 14:00 PM -
Impact of Route of Administration and HCP- or Self-Administration on Pricing of Non-Oncology Orphan Products, 2015-2024
Mar 10, 2025, 14:00 PM -
Costs and Resource Optimization in the Rheumatoid Arthritis Care Pathway: A TDABC-Based Analysis in a Clinic in São Paulo
Mar 10, 2025, 14:00 PM
